Search research articles
Contact Us
Filters
Showing results (21-30 of 29) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 29 results.
Journal of Molecular Biology
|
February 23, 2013
Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potential
Ciara M Mahon, Matthew A Lambert, Jacob Glanville, et al.
Journal of Medicinal Chemistry
|
July 24, 2023
Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates
Jeremy R Duvall, Joshua D Thomas, Raghida A Bukhalid, et al.
Molecular Cancer Therapeutics
|
February 14, 2024
Development of a Novel DNA Mono-alkylator Platform for Antibody-Drug Conjugates
Joshua D Thomas, Aleksandr V Yurkovetskiy, Mao Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells
Raghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2015
Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions
Marc Damelin, Alexander Bankovich, Albert Park, et al.
Molecular Cancer Therapeutics
|
September 29, 2023
Site-Specific Dolasynthen Antibody-Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles across a Wide Range of Drug-to-Antibody Ratios
Susan M Clardy, Alex Uttard, Bingfan Du, et al.
Cancer Research
|
May 5, 2011
Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells
Marc Damelin, Kenneth G Geles, Maximillian T Follettie, et al.
Science Translational Medicine
|
January 13, 2017
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
Marc Damelin, Alexander Bankovich, Jeffrey Bernstein, et al.
Molecular Cancer Therapeutics
|
June 9, 2023
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of Cancer
Dorin Toader, Shawn P Fessler, Scott D Collins, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 29) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 29 results.
Journal of Molecular Biology
|
February 23, 2013
Comprehensive interrogation of a minimalist synthetic CDR-H3 library and its ability to generate antibodies with therapeutic potential
Ciara M Mahon, Matthew A Lambert, Jacob Glanville, et al.
Journal of Medicinal Chemistry
|
July 24, 2023
Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates
Jeremy R Duvall, Joshua D Thomas, Raghida A Bukhalid, et al.
Molecular Cancer Therapeutics
|
February 14, 2024
Development of a Novel DNA Mono-alkylator Platform for Antibody-Drug Conjugates
Joshua D Thomas, Aleksandr V Yurkovetskiy, Mao Yin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2025
XMT-2056, a HER2-Directed STING Agonist Antibody-Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells
Raghida A Bukhalid, Jeremy R Duvall, Kelly Lancaster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2015
Anti-EFNA4 Calicheamicin Conjugates Effectively Target Triple-Negative Breast and Ovarian Tumor-Initiating Cells to Result in Sustained Tumor Regressions
Marc Damelin, Alexander Bankovich, Albert Park, et al.
Molecular Cancer Therapeutics
|
September 29, 2023
Site-Specific Dolasynthen Antibody-Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles across a Wide Range of Drug-to-Antibody Ratios
Susan M Clardy, Alex Uttard, Bingfan Du, et al.
Cancer Research
|
May 5, 2011
Delineation of a cellular hierarchy in lung cancer reveals an oncofetal antigen expressed on tumor-initiating cells
Marc Damelin, Kenneth G Geles, Maximillian T Follettie, et al.
Science Translational Medicine
|
January 13, 2017
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
Marc Damelin, Alexander Bankovich, Jeffrey Bernstein, et al.
Molecular Cancer Therapeutics
|
June 9, 2023
Discovery and Preclinical Characterization of XMT-1660, an Optimized B7-H4-Targeted Antibody-Drug Conjugate for the Treatment of Cancer
Dorin Toader, Shawn P Fessler, Scott D Collins, et al.
Page
of 3